| Vol. 5.08 – 5 March, 2021 |
| |
|
|
| Cell proliferation tracing revealed that, at the whole hepatocyte–population level, more proliferation was detected in a subset of midzonal hepatocytes during liver homeostasis, with less proliferation in periportal hepatocytes and minimal proliferation in pericentral hepatocytes. [Science] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors validated the increased N6‐methyladenosine (m6A) modification and elevated YTHDF1 protein level in sublethal‐heat‐treated hepatocellular carcinoma (HCC) cell lines, HCC patient‐derived xenograft mouse model and patients’ HCC tissues. [Hepatology] |
|
|
|
| Researchers found that Sirtuin 2 (SIRT2) was significantly downregulated in livers from advanced NAFLD patients and high‐fat diet (HFD)‐induced non-alcoholic liver disease mice. They revealed that SIRT2 was markedly decreased in obese mice and in palmitate‐treated HepG2 cells. [Hepatology] |
|
|
|
| Scientists revealed that USP39 was highly expressed in human hepatocellular carcinoma (HCC) tissues and correlated with poor prognosis. USP39 depletion inhibited HCC cell proliferation and metastasis by promoting ZEB1 degradation. [Cell Death & Differentiation] |
|
|
|
| The genetic reintroduction of BLOC1S1 rescued lysosomal tubulation in liver-specific knockout hepatocytes, but not when KIF5B was concurrently depleted. [Autophagy] |
|
|
|
| Researchers investigated differential expression of microRNAs between PiZ and control mice and found that miR-34b/c was up-regulated and its levels correlated with intrahepatic Z α1-antitrypsin. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| The authors discovered that targeting EphA2 suppressed both AKT and JAK1/STAT3 signaling, two separate oncogenic pathways in hepatocelllar carcinoma. [Cell Reports] |
|
|
|
| Genetic ablation or depletion of PPM1A in cells, organoids, and mice elicited an enhanced Yes-associated protein (YAP)/TAZ cytoplasmic retention and resulted in the diminished cell proliferation, severe gut regeneration defects in colitis, and impeded liver regeneration upon injury. [PLoS Biology] |
|
|
|
| Investigators report that TPC2 knockout reduced proliferation of cancer cells in vitro, affected their energy metabolism, and successfully abrogated tumor growth in vivo. [Cell Chemical Biology] |
|
|
|
| Researchers investigated the level of human antigen R in the liver of mice fed a normal chow diet and a high-fat diet. [Cell Death & Disease] |
|
|
|
| In vitro experiments showed that in the human normal hepatocyte cell line LO2 and primary hepatocytes isolated from mice, overexpression of WW domain-binding protein 2 (WBP2) reduced fat deposition, and knocking out or knocking down WBP2 aggravated PA-induced fat deposition. [Cell Death & Disease] |
|
|
|
| Scientists reported that LOC554202 expression was distinctly upregulated in HCC specimens and cell lines. [Cancer Gene Therapy] |
|
|
|
|
| The authors summarize currently available adult cell‐derived hepatobiliary organoid models and their applications. [Hepatology] |
|
|
|
| Scientists summarize the latest advances in the understanding of fibroblast growth factor signaling in hepatic fibrosis. [Liver International] |
|
|
|
|
| Tempest Therapeutics, Inc. announced a clinical collaboration agreement with F. Hoffmann-La Roche Ltd. The collaboration will evaluate TPST-1120, Tempest’s small molecule PPAR⍺ antagonist, in combination with atezolizumab and bevacizumab in previously untreated patients with advanced hepatocellular carcinoma. [Tempest Therapeutics, Inc.] |
|
|
|
|
| April 21 – 23, 2021 Virtual |
|
|
|
|
|
| Shanghai Jiao Tong University School of Medicine- Shanghai, China |
|
|
|
| Cancer Research Center of Lyon – Lyon, France |
|
|
|
| CyberCoders – San Diego, California, United States |
|
|
|
| The Francis Crick Institute – London, England, United Kingdom |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
|